Exendin-4, a GLP-1 receptor agonist, directly induces adiponectin expression through protein kinase A pathway and

Le Thi Kim Chung1, Toshio Hosaka, Masaki Yoshida

  • 1Department of Nutrition and Metabolism, Institute of Health Biosciences, University of Tokushima Graduate School, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.

Insights

Exendin-4 (Ex-4), a type 2 diabetes drug, boosts adiponectin secretion in fat cells via the glucagon-like peptide-1 receptor (GLP-1R) and protein kinase A pathway. It also reduces inflammatory adipokines, potentially improving insulin resistance.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Metabolic Research

Background:

  • Exendin-4 (Ex-4) is a glucagon-like peptide-1 receptor (GLP-1R) agonist used for type 2 diabetes.
  • The impact of Ex-4 on adipokine secretion remains largely unexplored.

Purpose of the Study:

  • To investigate the effect of Ex-4 on adipokine expression and secretion in 3T3-L1 adipocytes.
  • To elucidate the molecular mechanisms underlying Ex-4's influence on adiponectin.

Main Methods:

  • Treatment of 3T3-L1 adipocytes with Ex-4.
  • Measurement of adiponectin mRNA and protein levels.
  • Inhibition studies using forskolin, IBMX, and H89 to explore signaling pathways.

Main Results:

  • Ex-4 significantly increased adiponectin secretion and mRNA levels in 3T3-L1 adipocytes.
  • The Ex-4-induced adiponectin increase was mediated through the GLP-1R and the protein kinase A (PKA) pathway.
  • Ex-4 decreased the mRNA levels of inflammatory adipokines.
  • Forskolin, IBMX, and H89 inhibited the Ex-4-induced adiponectin expression.

Conclusions:

  • Ex-4 directly stimulates adiponectin secretion in adipocytes via the PKA signaling pathway.
  • Ex-4 may ameliorate insulin resistance by modulating adipokine profiles.

Related Concept Videos

Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...